Treatment of pediatric Crohn's disease patients with early perianal complications
Adler J, Gadepalli S, Zacur G, Jarboe M, Dombkowski K. Treatment of pediatric Crohn's disease patients with early perianal complications. Inflamm Bowel Dis 24 2018;(S1): S79
"A Guide to Gutsy Living": Patient Driven Development of a Pediatric Ostomy Toolkit
David J, Jofriet A, Seid M, Margolis PA. "A Guide to Gutsy Living": Patient Driven Development of a Pediatric Ostomy Toolkit. Pediatrics 2018;141(5): e20172789
Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure
Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. Gastroenterology 154 2018;(6): S670
Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort. Gastroenterology 154 2018;(6): S669-670
Evaluation of adalimumab effectiveness in pediatric patients with ulcerative colitis in clinical practice
Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R, ImproveCareNow Network. Evaluation of adalimumab effectiveness in pediatric patients with ulcerative colitis in clinical practice. Gastroenterology 154 2018;(6): S668-669
Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort. Gastroenterology 154 2018;(6): S669
Uveitis in a multicenter pediatric inflammatory bowel disease population: results from the Improvecarenow Network
Schaefer M, Nelson A, Sanchez R. Uveitis in a multicenter pediatric inflammatory bowel disease population: results from the Improvecarenow Network. Gastroenterology 154 2018;(6): S669
Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice
Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R, ImproveCareNow Network. Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice. J Pediatr Gastroenterol Nutr 66 2018;(2): S41
Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure
Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. J Pediatr Gastroenterol Nutr 66 2018;(2): S563
Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort. J Pediatr Gastroenterol Nutr 66 2018;(2): S84
Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort. J Pediatr Gastroenterol Nutr 66 2018;(2): S96
Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry
Hensel K, Cunion D, Gasparetto M, Brennan M, Folan A, Lee C, Torrente F, Zilbauer M, Heuschkel R. Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry. J Pediatr Gastroenterol Nutr 66 2018;(2): S59
Use of cannabis and opiates by adolescents and young adults with inflammatory bowel disease
Hoffenberg E, Murphy B, Mikulich-Gilbertson S, McWilliams S, Hoffenberg A, Hopfer C. Use of cannabis and opiates by adolescents and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 67 2018;(S1): S62-63
Outcomes in pediatric IBD patients not receiving immunological therapies
Benkov KJ, Serphos D. Outcomes in pediatric IBD patients not receiving immunological therapies. J Pediatr Gastroenterol Nutr 67 2018;(S1): S191-192
Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure
Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. J Pediatr Gastroenterol Nutr 67 2018;(S1): S264-265